Clinical Trial Update: Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy

View source ↗

Summary

This clinical trial update reports on sustained viral response in chronic hepatitis B patients who achieved HBeAg seroconversion after interferon therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Beijing Ditan Hospital | Conditions: Chronic Hepatitis B | Status: UNKNOWN